RBC Capital Maintains Outperform on Insulet, Raises Price Target to $180
Benzinga Newsdesk 13 hours ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Kendall Au maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $160 to $180.
RBC Capital analyst Kendall Au maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $160 to $180.